This invention relates to glucagon-like peptide 2 (GLP-2) derivatives. In particular, this invention relates to GLP-2 peptide derivatives having an extended in vivo half-life, for the treatment or prevention of gastrointestinal disorders or diseases such as inflammatory bowel disease and other gastrointestinal functions, from any segment of the gastrointestinal tract, from the oesophagus to the anus.

 
Web www.patentalert.com

< Methods and compositions for regulating HDAC4 activity

< Sulfonated block copolymers, method for making same, and various uses for such block copolymers

> Antibody against uPA/uPAR

> Uses of monoclonal antibody 8H9

~ 00613